KfouryToll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis.
暂无分享,去创建一个
A. Viari | V. Hervieu | P. Saintigny | S. Lebecque | D. Durantel | B. Testoni | T. Renno | B. Vanbervliet | Y. Estornes | M. Bonnin | P. Merle | L. Lefrançois | I. Coste | Baptiste Guey | K. Weber | B. Bancel | A. Kfoury | N. Fares | F. Pez | Kévin Lang | Amandine I. Garcia | Birke Bartoch | Isabelle Coste
[1] N. Le Stang,et al. Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis , 2018, Cell Death & Disease.
[2] P. Giresi,et al. Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. , 2017, Cancer cell.
[3] N. Le Stang,et al. Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas. , 2016, Human pathology.
[4] M. Ait-goughoulte,et al. Expression and functionality of Toll- and RIG-like receptors in HepaRG cells. , 2015, Journal of hepatology.
[5] Ju-Seog Lee. The mutational landscape of hepatocellular carcinoma , 2015, Clinical and molecular hepatology.
[6] Gui-lan Wang,et al. TLR3 Plays Significant Roles against HBV-Associated HCC , 2015, Gastroenterology research and practice.
[7] J. Qin,et al. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis , 2015, BMC Cancer.
[8] M. Adib-Conquy,et al. TLR‐mediated activation of NK cells and their role in bacterial/viral immune responses in mammals , 2014, Immunology and cell biology.
[9] S. Akira,et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. , 2013, Immunity.
[10] M. Omary,et al. Toll Like Receptor 3 Plays a Critical Role in the Progression and Severity of Acetaminophen-Induced Hepatotoxicity , 2013, PloS one.
[11] T. Seya,et al. Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA , 2013, Nature Communications.
[12] J. Casanova,et al. Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor , 2013, The Journal of Immunology.
[13] N. Copeland,et al. Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients , 2012, Journal of the National Cancer Institute.
[14] L. Quintanilla‐Martinez,et al. Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. , 2012, Immunity.
[15] W. Wong,et al. Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming , 2012, Cell.
[16] S. Lebecque,et al. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8 , 2012, Cell Death and Differentiation.
[17] L. Pfeffer,et al. Activation of chemokine and inflammatory cytokine response in hepatitis C virus–infected hepatocytes depends on toll‐like receptor 3 sensing of hepatitis C virus double‐stranded RNA intermediates , 2012, Hepatology.
[18] D. Levy,et al. Induction and function of type I and III interferon in response to viral infection. , 2011, Current opinion in virology.
[19] I. Ng,et al. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma , 2011, Gut.
[20] Jennifer Bess,et al. Characterization of HCV Interactions with Toll-Like Receptors and RIG-I in Liver Cells , 2011, PloS one.
[21] S. Kwon,et al. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. , 2011, Gastroenterology.
[22] Masashi Suzuki,et al. Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway. , 2010, Oncology reports.
[23] S. Tsao,et al. Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells , 2010, BMC Cancer.
[24] M. Loh,et al. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. , 2010, Journal of hepatology.
[25] Elina Zorde-Khvalevsky,et al. Toll‐like receptor 3 signaling attenuates liver regeneration , 2009, Hepatology.
[26] Osamu Takeuchi,et al. Innate immunity to virus infection , 2009, Immunological reviews.
[27] H. Saya,et al. p53 Regulates Toll-Like Receptor 3 Expression and Function in Human Epithelial Cell Lines , 2008, Molecular and Cellular Biology.
[28] A. Filippini,et al. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. , 2008, Carcinogenesis.
[29] P. Romero,et al. Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy? , 2007, Clinical Cancer Research.
[30] H. Giladi,et al. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis , 2007, Journal of cellular biochemistry.
[31] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[32] S. Lebecque,et al. TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells1 , 2006, The Journal of Immunology.
[33] S. D. L. Monte,et al. Oncogenic role of the frizzled-7/β-catenin pathway in hepatocellular carcinoma , 2005 .
[34] Masahiro Ito,et al. Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis , 2005, Laboratory Investigation.
[35] S. Lemon,et al. Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in Hepatocytes* , 2005, Journal of Biological Chemistry.
[36] Christian Trépo,et al. Origin and characterization of a human bipotent liver progenitor cell line. , 2004, Gastroenterology.
[37] D. Weissman,et al. mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.
[38] Christian Trepo,et al. Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[40] G. Grimber,et al. Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. , 1991, Journal of hepatology.
[41] K. Shiraki,et al. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. , 2008, International journal of oncology.